| Synonyms: | |
| Status: | Approved (2018) |
| Entry Type: | Antibody |
| Molecule Category: | UNKNOWN |
| ATC: | L01XC34 |
| UNII: | 2NDX4B6N8F |
Pharmacology
| Primary Target | |
|---|---|
| CD22 |
Indications
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Leukemia, Hairy Cell | 4 | D007943 | FDA |
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 2 | D054198 | ClinicalTrials |
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 2 | D054198 | ClinicalTrials |
| Lymphoma | 1 | D008223 | ClinicalTrials |
| Lymphoma, Non-Hodgkin | 1 | D008228 | ClinicalTrials |
| Leukemia, Lymphocytic, Chronic, B-Cell | 1 | D015451 | ClinicalTrials |
| Leukemia | 1 | D007938 | ClinicalTrials |
Cross References
| Resources | Reference |
|---|---|
| CAS NUMBER | 1020748-57-5 |
| ChEMBL | CHEMBL1743043 |
| FDA SRS | 2NDX4B6N8F |
| Guide to Pharmacology | 7675 |
CONTENTS